RxDoctor Payments Data

Sam Mark

Podiatrist · Alexandria, VANPI 1770014193

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (52.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Supreme Orthopedic Systems, LLC at 38.9% of the total. Reporting peaked in 2021 at $1,260 and has fallen 55.6% since, to $560 in 2025.

$3,243in general payments, 2019–2025

Across 51 payments — averaging $63.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supreme Orthopedic Systems, LLC$1K
  • Linvatec Corporation$484
  • Smith+Nephew$252
  • Treace Medical Concepts, Inc.$249
  • Amgen$239
  • Medtronic$187
  • plus $572 from 19 others

What the payments were for

  • Travel & lodging$33910%
  • Food & beverage$1,70453%
  • Education$1,20037%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,243 in reported general payments places this provider in the 75th percentile of 126 podiatrist providers in Virginia.

See all podiatrist providers in Virginia

Medicare billing

Part B allowed, 2024
$249,902
Medicare patients
600
Services billed
2,858

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naftifine Hcl12$5,715
Ciclopirox83$3,636
CiclopiroxCiclopirox Olamine41$793
Ammonium Lactate46$674
Diclofenac Sodium16$541
Gabapentin16$441
Clotrimazole23$393
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip13$343
Mupirocin23$303
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen20$135
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav19$133
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim12$73
Meloxicam36$40

Paid to pharmacies, not to this prescriber.

Other podiatrist in Alexandria

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →